D.Sole

Your early warning and monitoring insole for diabetic foot complications.

D.Sole was founded in 2024, is headquartered in Pittsburgh, United States, lists 1–10 employees, and has $20K in recorded funding across 1 round.

Employees
1–10
Founded
2024
Business Model
B2B
Website
d-sole.com
Total Funding
$20K
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

D.Sole develops smart insoles embedded with multimodal sensors that enable early detection and continuous remote monitoring of diabetic foot complications, including ulcers caused by peripheral neuropathy. The system pairs hardware insoles with an AI-powered mobile app that delivers complete foot analysis reports and a clinician dashboard with evidence-based treatment algorithms. By providing real-time data to clinicians, D.Sole helps prevent severe ulcers and amputations, increases MIPS scores for value-based care organizations, and improves patient compliance through automated reminders.

Summary

D.Sole is a Healthcare company based in Pittsburgh, United States, founded in 2024. It lists 1–10 employees. It has raised $20K in total across 1 round. Investors include Techstars and SkyDeck Berkeley.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed Round
$20K

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

D.Sole on Indexed.vc
<a href="https://indexed.vc/companies/dsole"><img src="https://indexed.vc/api/badge/company/dsole" alt="D.Sole on Indexed.vc" width="260" height="76" /></a>